Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Home page url
Download or read it online for free here:
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.
- National Institutes of Health
This book about pharmacology explains how scientists unravel the many different ways medicines work in the body and how this information guides the hunt for drugs of the future. The book presents some of the latest research developments in the field.
by Ali Demir Sezer (ed.) - InTech
Since the advent of analytical techniques and capabilities to measure nanometer particles, there has been tremendous interest in the use of nanoparticles for drug delivery. This book collects reviews and original articles from eminent experts.
by Tarek A Leil, Sergey Ermakov (eds) - Frontiers Media S.A.
Quantitative Systems Pharmacology is still in its infancy, but has tremendous potential to change the way we approach biomedical research. QSP is really the integration of two disciplines: 'Systems Biology' and 'Quantitative Pharmacology'.